[HTML][HTML] microRNAs associated to anthracycline-induced cardiotoxicity in women with breast cancer: a systematic review and pathway analysis
Background Cardiotoxicity is a common and serious adverse effect of anthracycline therapy
in breast cancer patients. The current criteria for cardiotoxicity are based on imaging and …
in breast cancer patients. The current criteria for cardiotoxicity are based on imaging and …
microRNAs associated to anthracycline-induced cardiotoxicity in women with breast cancer: A systematic review and pathway analysis
JD Pereira, JAG Tosatti, R Simões… - Biomedicine & …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Cardiotoxicity is a common and serious adverse effect of anthracycline therapy
in breast cancer patients. The current criteria for cardiotoxicity are based on imaging and …
in breast cancer patients. The current criteria for cardiotoxicity are based on imaging and …
MicroRNAs associated to anthracycline-induced cardiotoxicity in women with breast cancer: a systematic review and pathway analysis
JD Pereira, JAG Tosatti, R Simões… - Biomedicine & …, 2020 - repositorio.ufmg.br
Background: Cardiotoxicity is a common and serious adverse effect of anthracycline therapy
in breast cancer patients. The current criteria for cardiotoxicity are based on imaging and …
in breast cancer patients. The current criteria for cardiotoxicity are based on imaging and …